# AGILE THERAPEUTICS INC

AGILE THERAPEUTICS INC is a company headquartered in Princeton, NJ, United States.

## Company overview

- **Legal name:** AGILE THERAPEUTICS INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Princeton, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001261249

## About

AGILE THERAPEUTICS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001261249, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-28, it reported annual revenue of USD 19,593,000; net income of USD -14,465,000; total assets of USD 10,255,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $19.6M (USD 19,593,000)
- **Net income:** -$14.5M (USD -14,465,000)
- **Total assets:** $10.3M (USD 10,255,000)
- **Cash and equivalents:** $2.6M (USD 2,557,000)
- **Operating cash flow:** -$9.6M (USD -9,577,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $10.9M (USD 10,884,000)
- **Net income:** -$25.4M (USD -25,412,000)
- **Total assets:** $14.2M (USD 14,242,000)
- **Cash and equivalents:** $5.2M (USD 5,246,000)
- **Operating cash flow:** -$35.9M (USD -35,947,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $4.1M (USD 4,101,000)
- **Net income:** -$74.9M (USD -74,894,000)
- **Total assets:** $39.3M (USD 39,333,000)
- **Cash and equivalents:** $19.1M (USD 19,143,000)
- **Operating cash flow:** -$65.2M (USD -65,202,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $749,000 (USD 749,000)
- **Net income:** -$51.9M (USD -51,853,000)
- **Total assets:** $73.1M (USD 73,062,000)
- **Cash and equivalents:** $14.5M (USD 14,463,000)
- **Operating cash flow:** -$47.3M (USD -47,311,000)

## Recent SEC filings

- Form 8-K — filed 2024-08-26 — period 2024-08-22 — FORM 8-K
- Form 10-Q — filed 2024-08-12 — period 2024-06-30 — 10-Q
- Form SC 13G — filed 2024-07-22
- Form SC 13G — filed 2024-07-09
- Form SC 13G — filed 2024-07-02
- Form 8-K — filed 2024-06-26 — period 2024-06-25 — 8-K
- Form S-1 — filed 2024-06-14 — FORM S-1
- Form 8-K — filed 2024-05-21 — period 2024-05-15 — 8-K
- Form 10-Q — filed 2024-05-15 — period 2024-03-31 — 10-Q
- Form 8-K — filed 2024-05-15 — period 2024-05-15 — 8-K
- Form 10-K/A — filed 2024-04-29 — period 2023-12-31 — 10-K/A
- Form 8-K — filed 2024-04-09 — period 2024-04-09 — 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/agile-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology